Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Bone Marrow Transplantation

• Publication date

  1999-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.bmt.1701736PMID 10338044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.

  1998cited by this paper
• The incidence of DNA aneuploidy in multiple myeloma does not correlate with stage of disease.

  1998cited by this paper
• Sensitivity of combined DNA/immunophenotype flow cytometry for the detection of low levels of aneuploid lymphoblastic leukemia cells in bone marrow.

  1997cited by this paper
• Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal

  1997cited by this paper
• A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.

  1996cited by this paper
• Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.

  1996cited by this paper
• A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

  1996cited by this paper
• Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor.

  1996cited by this paper
• A simple and sensitive method for determining plasma cell isotype and monoclonality in bone marrow using flowcytometry

  1995cited by this paper
• Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma

  1995cited by this paper
• Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma.

  1995cited by this paper
• High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting.

  1995cited by this paper
• Use of granulocyte colony‐stimulating factor (G‐CSF) for mobilizing peripheral blood stem cells: risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration

  1994cited by this paper
• Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML.

  1994cited by this paper
• Differences in relative DNA content between human peripheral blood and bone marrow subpopulations--consequences for DNA index calculations.

  1993cited by this paper
• Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

  1993cited by this paper
• Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology.

  1993cited by this paper
• Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B‐lymphocyte clones in a polyclonal population

  1990cited by this paper
• Markers of multiple hematopoietic-cell lineages in multiple myeloma.

  1990cited by this paper
• Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19).

  1990cited by this paper
• Cellular DNA content as a marker of human multiple myeloma.

  1980cited by this paper
• A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

  1975cited by this paper

• Relevance and clinical implications of tumor cell mobilization in the autologous transplant setting.

  2011cites this paper
• Klinische Bedeutung des Nachweises minimaler Residualerkrankung bei Leukämien, Lymphomen und soliden Tumoren

  2006cites this paper
• Flow Cytometric DNA Analysis in Oncology: From Single to Multiparametric Measurements/Durchflusszytometrische DNA-Analytik in der Onkologie: Von einzel- zu multiparametrischen Messungen

  2003cites this paper
• The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.

  2003cites this paper
• REVIEW ARTICLE The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Multiple Myeloma: An Evidence-Based Review

  2003cites this paper
• Efficacy and safety of CD34-selected and CD19-depleted autografting in multiple myeloma patients: a pilot study.

  2002cites this paper
• Diagnostic and prognostic value of flow cytometric immunophenotyping in malignant hematological diseases.

  2002cites this paper
• Flow cytometric analysis of lymphomas and lymphoproliferative disorders.

  2001cites this paper
• Flow cytometric DNA-quantification of three-color immunophenotyped cells for subpopulation specific determination of aneuploidy and proliferation.

  2001cites this paper
• CARCINOEMBRYONIC ANTIGEN ELEVATION IN AGNOGENIC MYELOID METAPLASIA

  2000cites this paper
• Some limitations in the detection of residual aneuploid cells with dna quantification on immunophenotyped cells by flow cytometry

  2000cites this paper
• Carcinoembryonic antigen elevation in agnogenic myeloid metaplasia

  2000cites this paper
• Hematotherapy LiteratureWatch

  1999cites this paper
• Hematotherapy LiteratureWatch

  1999cites this paper